New study confirms breast cancer risk of HRT
Unique medical device offers menopausal women a safe alternative
New research has reignited the link between hormone replacement therapy (HRT) and breast cancer, after scientists found that HRT increases the risk of breast cancer among older women. This latest study confirms the findings of several previous studies that HRT increases the risk of breast cancer in addition to ovarian and womb cancers.
Researchers at Harbor-UCLA Medical Center in Los Angeles discovered that women who took HRT for as little as two years increased their risk of breast cancer and when they stopped, their risk levels returned to normal within two years.
Dr Nyjon Eccles BSc MBBS PhD MRCP says: “This is further proof of the link between HRT and cancers and provides a compelling reason for women to consider a drug free option to treat their menopausal symptoms. HRT is potentially harmful for some women. I am therefore not surprised that over 170,000 women in the UK have been seeking relief from LadyCare – a natural, drug free medical device that can help relieve the symptoms associated with the menopause.”
Researchers for the Harbor-UCLA study reviewed findings from the Women’s’ Health Initiative study, published back in 2002. The study was halted when it was discovered that HRT was increasing participants’ risk of breast cancer, heart disease and stroke but that risk rates fell again when they stopped taking the HRT pills.
LadyCare is a unique device which is believed to help balance mood and alleviate physical symptoms of menopause, allowing women to get on with their day-to-day and enjoy life to the full. Simply attached onto a woman’s underwear and out of sight, LadyCare is small and discreet and worn continuously over the pelvic area to bring relief from the symptoms of the menopause.
Dr Nyjon Eccles BSc MBBS PhD MRCP says:
“As the scientific evidence continues to link HRT to cancers, women are becoming more and more concerned. The decision to take HRT is a personal one but with a natural drug-free option available, women can take advantage of having more choice in making their decision.”
“In a recent three month study of 508 menopausal women, LadyCare was found to have a significant reduction (in most cases 60% or more reduction) of symptoms associated with menopause including sleep deprivation, hot flushes, mood swings. As a result LadyCare seems to be an ideal choice for any woman who is looking for a safe and natural way to manage their menopause.”
LadyCare costs £19.95 and is available from Boots, Lloyds Pharmacy, Waitrose or online at www.ladycare-uk.com.
For further information or case studies please contact:
Amy Franklin, Tiger White PR, 020 7202 8520 / firstname.lastname@example.org
Joanne Jarvis, Tiger White PR, 020 7202 8520 / email@example.com
Lizzie Andrews, Tiger White PR, 020 7202 8520 / firstname.lastname@example.org
According to new research by researchers Harbor-UCLA Medical Center in Los Angeles presented at the San Antonio Breast Cancer Symposium, December 2008
UK’s Million Woman Study, 1997, Cancer Research UK Epidemiology Unit concludes that HRT increases the risk of ovarian and womb cancers, in addition to breast cancer
The Million Women Study, 1997 Cancer Research UK Epidemiology Unit in Oxford, UK
Dr Nyjon. K. Eccles: Survey to determine the effect of the static magnetic device, LadyCare, on menopause symptoms, 2005
This press release was distributed by ResponseSource Press Release Wire on behalf of Tiger White PR in the following categories: Health, Women's Interest & Beauty, for more information visit https://pressreleasewire.responsesource.com/about.